Economy

Author(s):  
Mira Kamdar

What is the size of India’s economy and how fast is it growing? In terms of purchasing power parity, India’s $2.3 trillion economy ranked third in the world after the United States and China in 2016. Purchasing power parity means a comparison of economies in...

Author(s):  
V. G. VARNAVSKIY

The article considers the USA role and place in the global  manufacturing and trade. Key aspects of the world economy  transformation in the context of globalization, internationalization  and liberalization are studied. As shows, USA and China are the two  largest economies in the world. United States is the world’s largest  economy by nominal GDP and second largest by purchasing power  parity (PPP). It holds a 15.4 percent share of global GDP in PPP  (2016). China is the world’s largest economy by PPP, accounting for  17.8 percent of global GDP. The USA share of world GDP declined by  a total of 3.8 percentage points between 2006 and 2016. At the  same time, the United States possesses great economic strength. It  is also the world leader in innovation. China’s success has mostly  been in lowerend innovation. This country has been less successful in  higher-end innovation, where USA currently maintain a lead. The  United States holds a leading position in aerospace, instrument  making, cloud computing, ICT, robotics-related technologies, nanomaterials, biopharmaceutical and other high-tech  industries and China significantly lags behind. Special attention is paid to the U.S. foreign trade. It is shown that the USA is one of  the world’s largest importer and exporter of goods and services. It  accounts for 10.5 percent of global goods and services exports in  2016 (second place after China) and 13.3 percent of global imports  (first place). Despite the world’s second place after China in some economic indexes such as gross domestic product (at PPP),   size of manufacturingand merchandise trade, USA ranks first in the  world in terms of quality indicators of economic development. It  remains the most powerful economy in the world. The author’s  conclusion is that, the loss of US world leadership in terms of output  indicators has not yet become a global problem for other countries  and world economy in the whole.


2012 ◽  
Vol 14 (1) ◽  
Author(s):  
Antonio Bojanic

This paper focuses on the use of silver as a monetary standard in Mexico during approximately the last three decades of the nineteenth century and the first decade of the twentieth century. During this period, several events occurred in the market for silver that affected those countries attached to this metal. These events caused some of these countries to abandon silver for good and adopt other types of monetary arrangements. Mexico and a few others chose to stay with it.The reasons behind this decision are analyzed. Additionally, evidence that supports the theory of purchasing power parity between Mexico and the United States is also presented and analyzed.


2021 ◽  
Vol 19 (2) ◽  
pp. 29-47
Author(s):  
Gavin George ◽  
Bruce Rhodes ◽  
Christine Laptiste

The teaching stock within the Caribbean region has been eroded by migration to developed countries. Higher potential earnings are one of the motivating factors to move abroad, but little is known about the extent of the income disparity between countries in the Caribbean and popular destination countries. Teacher salary comparisons are undertaken between selected countries in the Caribbean; Suriname, Trinidad and Tobago, St. Lucia, and Jamaica and popular destination countries, namely; United Kingdom, United States, and Canada using a purchasing power parity (PPP) exchange rate. Results show that newly qualified teachers can earn substantially more abroad, with Canada paying over twice the PPP adjusted salary compared to that offered in Jamaica (133.1%) and Suriname (110.6%). The United States offers the highest earning increases for mid- and late career teachers at over three times that offered in Jamaica (214.5%) and Suriname (223.4%). Canada is a close second across all Caribbean countries, whilst the United Kingdom offers the smallest salary differentials at 153.6% for Jamaica and 64.8% for St. Lucia. The study further reveals that there are salary disparities within the Caribbean, which may be a motivating factor for intra-regional migration.


2020 ◽  
Vol 36 (05) ◽  
pp. 665-669
Author(s):  
Anisha R. Kumar ◽  
Lisa E. Ishii ◽  
Ira Papel ◽  
Theda C. Kontis ◽  
David Chen ◽  
...  

AbstractThis study demonstrates that the trend of how rhytidectomy is valued can be used to determine not only the pricing of this good but also how receptive developing economic markets are to the export of cosmetic facial plastic surgery. This study seeks to analyze and compare the value of rhytidectomy in an established market and an emerging market. A cross-sectional survey was administered through public online forums to 162 casual observers in the United States and 74 casual observers in India. Participants were shown pre- and postoperative photos of 10 patients who underwent cosmetic rhinoplasty and 2 patients who did not undergo surgery. Observers were asked to quantify the perceived change in attractiveness, change in age, and willingness to pay (WTP). There is a similar nonlinear trend between WTP and change in attractiveness in both the United States and India. Baseline values of rhytidectomy in the United States and India have a similar ratio of 2.122 compared with the ratio between both countries in the 2018 Big Mac index. The comparison of the trend in WTP in the United States and India shows that facial cosmetic surgery functions as a luxury good in both an established market and an emerging market. Our model successfully approximates the relationship between each country's purchasing power parity. Since the market behavior of rhytidectomy can be predicted based on purchasing power parity, there may be an untapped market for facial cosmetic surgery among populations with growing economies.


2021 ◽  
Vol 61 (1) ◽  
Author(s):  
Gabriela Bittencourt Gonzalez Mosegui ◽  
Fernando Antõnanzas ◽  
Cid Manso de Mello Vianna ◽  
Paula Rojas

Abstract Background The objective of this paper is to analyze the prices of biological drugs in the treatment of Rheumatoid Arthritis (RA) in three Latin American countries (Brazil, Colombia and Mexico), as well as in Spain and the United States of America (US), from the point of market entry of biosimilars. Methods We analyzed products authorized for commercialization in the last 20 years, in Brazil, Colombia, and Mexico, comparing them to the United States of America (USA) and Spain. For this analysis, we sought the prices and registries of drugs marketed between 1999 and October 1, 2019, in the regulatory agencies’ databases. The pricing between countries was based on purchasing power parity (PPP). Results The US authorized the commercialization of 13 distinct biologicals and four biosimilars in the period. Spain and Brazil marketed 14 biopharmaceuticals for RA, ten original, four biosimilars. Colombia and Mexico have authorized three biosimilars in addition to the ten biological ones. For biological drug prices, the US is the most expensive country. Spain’s price behavior seems intermediate when compared to the three LA countries. Brazil has the highest LA prices, followed by Mexico and Colombia, which has the lowest prices. Spain has the lowest values in PPP, compared to LA countries, while the US has the highest prices. Conclusion The economic effort that LA countries make to access these medicines is much higher than the US and Spain. The use of the PPP ensured a better understanding of the actual access to these inputs in the countries analyzed.


Sign in / Sign up

Export Citation Format

Share Document